Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Global pharmaceutical company GlaxoSmithKline (GSK) has completed an investment of $7m in two production lines at its Brasov plant in Romania over a three-year period.
Subscribe to our email newsletter
The investment is intended for the manufacturing of the antidepressant Seroxat and the HIV treatment Retrovir, thediplomat.ro reported.
The company is said to export drugs to more than 80 countries, which is greater than 50 nations at the end of last year.
France and Italy consitute almost 24% of the company’s total exports.